J30.1
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: self-reported or doctor-diagnosed grass pollen allergy specific IgE against grass pollen (Phadia ImmunoCAP g6) = 0.7 self-reported seasonal symptoms to grass pollen with or without concomitant allergic asthma with or without allergy to other pollen types concomitant sensitisation (sIgE) to house dust mites is not an automatic exclusion criterion if no corresponding symptoms are reported written consent to participate in the study
Exclusion criteria
Exclusion criteria: known or suspected idiopathic/chronic rhinitis known chronic sinusitis known nasal polyposis long-term systemic therapy with immunosuppressants and/or steroids current and/or recent allergen-specific immunotherapy for grass pollen (since then current symptom severity cannot be estimated) perennial (year-round) allergy, e.g. to house dust mites or animal hair (with simultaneous exposure to animal hair) with significant symptoms planned trips during the study period that last longer than 2 weeks continuously, especially if the destination is >100 km away
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rhinitis-related quality of life (mini-RQLQ before-after intervention; feedback questionnaire) | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptom severity (symptom score of app diary; only groups 2 and 3), exposure-relevant behavior (app diary), self-reported usefulness of the app (feedback QR), symptom forecast. | — |
Countries
Germany
Contacts
Universität Augsburg